Skip to main content
Bart Clarke, MD, Endocrinology, Rochester, MN, Mayo Clinic Hospital - Rochester

BartLClarkeMD

Endocrinology Rochester, MN

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid

Professor of Medicine

Dr. Clarke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Clarke's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1986 - 1989
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 1986

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1987 - 2024
  • IA State Medical License
    IA State Medical License 1998 - 2006
  • IL State Medical License
    IL State Medical License 1994 - 1999
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Fellow (FACP) American College of Physicians, 1996
  • Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 Inhibitor 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Opening Comments: 2018 Parathyroid Summit: A Focus on Hypoparathyroidism 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
  • PTH Replacement Therapy in Hypoparathyroidism: When and How to Proceed 
    ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018

Press Mentions

  • Providers and Patients Can Help Minimize Risks of Steroid-Induced Osteoporosis, ACR Says
    Providers and Patients Can Help Minimize Risks of Steroid-Induced Osteoporosis, ACR SaysSeptember 22nd, 2022
  • Hormonal Regulation of Biomineralization
    Hormonal Regulation of BiomineralizationMarch 16th, 2021
  • Adynamic Bone Disease: Revisited
    Adynamic Bone Disease: RevisitedMarch 9th, 2021
  • Join now to see all

Committees

  • Co-Chair, ASBMR Development Committee 2014 - Present
  • Member, ASBMR Council 2013 - Present
  • Member, The Endocrine Society Development Committee 2009 - Present
  • Member, FDA Advisory Committee on Reproductive Health Drugs 2010 - 2013

Professional Memberships

Other Languages

  • French

Hospital Affiliations